Goddard Colin

Avg. Two Year Performance

No purchase track record
14% Avg. Sale Return
7% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return0%0%0%0%0%
Purchase Success Rate0 of 20 of 20 of 20 of 20 of 2
Average Sale Return(2%)2%(< 1%)12%14%
Sale Success Rate7 of 1810 of 1811 of 1812 of 1813 of 18

OSI Pharmaceuticals Inc.

Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Human Genome Sciences Inc.

Drugs » Diagnostic Substances

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Endocyte, Inc.

Drugs » Drug Manufacturers - Major

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--